Bruker Corporation (BRKR)
USD 36.32
(-3.56%)
USD 36.32
(-3.56%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 891.3 Million USD | 55.36% |
| 2022 | 573.7 Million USD | 115.68% |
| 2021 | 266 Million USD | 26.85% |
| 2020 | 209.7 Million USD | 15.22% |
| 2019 | 182 Million USD | 873.26% |
| 2018 | 18.7 Million USD | -79.36% |
| 2017 | 90.6 Million USD | 30.74% |
| 2016 | 69.3 Million USD | 17425.0% |
| 2015 | -400 Thousand USD | -101.13% |
| 2014 | 35.5 Million USD | 142.41% |
| 2013 | -83.7 Million USD | -414.66% |
| 2012 | 26.6 Million USD | -53.42% |
| 2011 | 57.1 Million USD | -19.12% |
| 2010 | 70.6 Million USD | 201.73% |
| 2009 | -69.4 Million USD | -220.49% |
| 2008 | 57.6 Million USD | 265.68% |
| 2007 | -34.76 Million USD | -368.1% |
| 2006 | -7.42 Million USD | 68.71% |
| 2005 | -23.73 Million USD | -419.82% |
| 2004 | 7.42 Million USD | 141.97% |
| 2003 | -17.68 Million USD | -101.72% |
| 2002 | -8.76 Million USD | -228.39% |
| 2001 | 6.82 Million USD | 170.4% |
| 2000 | -9.69 Million USD | -175.2% |
| 1999 | 12.89 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 2.14 Billion USD | 2.34% |
| 2024 Q1 | 1.12 Billion USD | 26.12% |
| 2024 Q2 | 2.1 Billion USD | 86.82% |
| 2023 Q2 | 668.6 Million USD | 5.93% |
| 2023 FY | 891.3 Million USD | 55.36% |
| 2023 Q1 | 631.2 Million USD | 10.02% |
| 2023 Q3 | 856 Million USD | 28.03% |
| 2023 Q4 | 891.3 Million USD | 4.12% |
| 2022 Q4 | 573.7 Million USD | 8.74% |
| 2022 FY | 573.7 Million USD | 115.68% |
| 2022 Q1 | 400.3 Million USD | 50.49% |
| 2022 Q2 | 462 Million USD | 15.41% |
| 2022 Q3 | 527.6 Million USD | 14.2% |
| 2021 Q4 | 266 Million USD | 4.72% |
| 2021 FY | 266 Million USD | 26.85% |
| 2021 Q2 | 221.2 Million USD | 73.63% |
| 2021 Q3 | 254 Million USD | 14.83% |
| 2021 Q1 | 127.4 Million USD | -39.25% |
| 2020 Q2 | 320.5 Million USD | 23.55% |
| 2020 Q1 | 259.4 Million USD | 42.53% |
| 2020 Q3 | 304.9 Million USD | -4.87% |
| 2020 Q4 | 209.7 Million USD | -31.22% |
| 2020 FY | 209.7 Million USD | 15.22% |
| 2019 Q1 | 94.1 Million USD | 403.21% |
| 2019 Q4 | 182 Million USD | -33.38% |
| 2019 Q3 | 273.2 Million USD | 2.28% |
| 2019 FY | 182 Million USD | 873.26% |
| 2019 Q2 | 267.1 Million USD | 183.85% |
| 2018 FY | 18.7 Million USD | -79.36% |
| 2018 Q2 | -38.1 Million USD | 39.81% |
| 2018 Q3 | -29.5 Million USD | 22.57% |
| 2018 Q4 | 18.7 Million USD | 163.39% |
| 2018 Q1 | -63.3 Million USD | -169.87% |
| 2017 Q3 | 216.6 Million USD | 1.64% |
| 2017 FY | 90.6 Million USD | 30.74% |
| 2017 Q4 | 90.6 Million USD | -58.17% |
| 2017 Q1 | 107.3 Million USD | 54.83% |
| 2017 Q2 | 213.1 Million USD | 98.6% |
| 2016 FY | 69.3 Million USD | 17425.0% |
| 2016 Q2 | 110.5 Million USD | 19.72% |
| 2016 Q3 | 86.2 Million USD | -21.99% |
| 2016 Q1 | 92.3 Million USD | 23175.0% |
| 2016 Q4 | 69.3 Million USD | -19.61% |
| 2015 Q2 | 43.8 Million USD | 117.91% |
| 2015 Q4 | -400 Thousand USD | -100.99% |
| 2015 Q3 | 40.4 Million USD | -7.76% |
| 2015 FY | -400 Thousand USD | -101.13% |
| 2015 Q1 | 20.1 Million USD | -43.38% |
| 2014 Q2 | -34.1 Million USD | 65.63% |
| 2014 Q4 | 35.5 Million USD | 36.54% |
| 2014 Q3 | 26 Million USD | 176.25% |
| 2014 Q1 | -99.2 Million USD | -18.52% |
| 2014 FY | 35.5 Million USD | 142.41% |
| 2013 Q2 | 85.6 Million USD | 27.38% |
| 2013 Q3 | 48.9 Million USD | -42.87% |
| 2013 FY | -83.7 Million USD | -414.66% |
| 2013 Q1 | 67.2 Million USD | 152.63% |
| 2013 Q4 | -83.7 Million USD | -271.17% |
| 2012 Q3 | 94.8 Million USD | 17.62% |
| 2012 FY | 26.6 Million USD | -53.42% |
| 2012 Q2 | 80.6 Million USD | -10.54% |
| 2012 Q4 | 26.6 Million USD | -71.94% |
| 2012 Q1 | 90.1 Million USD | 57.79% |
| 2011 FY | 57.1 Million USD | -19.12% |
| 2011 Q3 | 115.6 Million USD | -2.03% |
| 2011 Q2 | 118 Million USD | 15.57% |
| 2011 Q1 | 102.1 Million USD | 44.62% |
| 2011 Q4 | 57.1 Million USD | -50.61% |
| 2010 Q1 | -69.9 Million USD | -0.72% |
| 2010 FY | 70.6 Million USD | 201.73% |
| 2010 Q4 | 70.6 Million USD | 206.01% |
| 2010 Q3 | -66.6 Million USD | -9.36% |
| 2010 Q2 | -60.9 Million USD | 12.88% |
| 2009 Q1 | 55.2 Million USD | -4.17% |
| 2009 Q4 | -69.4 Million USD | -2578.57% |
| 2009 Q3 | 2.8 Million USD | -84.53% |
| 2009 FY | -69.4 Million USD | -220.49% |
| 2009 Q2 | 18.1 Million USD | -67.21% |
| 2008 Q1 | 124.26 Million USD | 457.42% |
| 2008 Q3 | 129.59 Million USD | 11.0% |
| 2008 Q4 | 57.6 Million USD | -55.55% |
| 2008 Q2 | 116.75 Million USD | -6.04% |
| 2008 FY | 57.6 Million USD | 265.68% |
| 2007 Q3 | 188 Thousand USD | 102.09% |
| 2007 Q2 | -8.97 Million USD | 57.89% |
| 2007 FY | -34.76 Million USD | -368.1% |
| 2007 Q1 | -21.3 Million USD | -186.91% |
| 2007 Q4 | -34.76 Million USD | -18592.55% |
| 2006 FY | -7.42 Million USD | 68.71% |
| 2006 Q4 | -7.42 Million USD | -160.64% |
| 2006 Q3 | 12.24 Million USD | 118.84% |
| 2006 Q2 | -65.01 Million USD | -81.29% |
| 2006 Q1 | -35.86 Million USD | -51.1% |
| 2005 Q1 | -42.81 Million USD | -677.0% |
| 2005 Q2 | -58.85 Million USD | -37.45% |
| 2005 FY | -23.73 Million USD | -419.82% |
| 2005 Q4 | -23.73 Million USD | 62.06% |
| 2005 Q3 | -62.55 Million USD | -6.29% |
| 2004 FY | 7.42 Million USD | 141.97% |
| 2004 Q1 | -27.39 Million USD | -54.92% |
| 2004 Q2 | -32.76 Million USD | -19.62% |
| 2004 Q3 | -31.32 Million USD | 4.39% |
| 2004 Q4 | 7.42 Million USD | 123.69% |
| 2003 Q1 | -19.47 Million USD | -122.22% |
| 2003 Q4 | -17.68 Million USD | 19.1% |
| 2003 Q3 | -21.85 Million USD | -33.61% |
| 2003 Q2 | -16.35 Million USD | 16.02% |
| 2003 FY | -17.68 Million USD | -101.72% |
| 2002 Q2 | 13.92 Million USD | 23.38% |
| 2002 Q1 | 11.28 Million USD | 65.31% |
| 2002 FY | -8.76 Million USD | -228.39% |
| 2002 Q4 | -8.76 Million USD | -194.12% |
| 2002 Q3 | 9.31 Million USD | -33.12% |
| 2001 Q3 | 8.12 Million USD | 166.28% |
| 2001 FY | 6.82 Million USD | 170.4% |
| 2001 Q4 | 6.82 Million USD | -16.0% |
| 2001 Q2 | 3.05 Million USD | 178.98% |
| 2001 Q1 | 1.09 Million USD | 111.28% |
| 2000 Q4 | -9.69 Million USD | 89.6% |
| 2000 Q1 | 11.01 Million USD | 0.0% |
| 2000 FY | -9.69 Million USD | -175.2% |
| 2000 Q2 | 14.73 Million USD | 33.72% |
| 2000 Q3 | -93.22 Million USD | -732.91% |
| 1999 FY | 12.89 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -3191.116% |
| BrainsWay Ltd. | -10.32 Million USD | 8736.628% |
| Cerus Corporation | 84.35 Million USD | -956.644% |
| Envoy Medical, Inc. | -3.81 Million USD | 23469.166% |
| electroCore, Inc. | -9.95 Million USD | 9053.29% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 17491.22% |
| IceCure Medical Ltd | -9.93 Million USD | 9072.217% |
| Inogen, Inc. | -103.56 Million USD | 960.586% |
| OrthoPediatrics Corp. | -9.26 Million USD | 9717.999% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 24579.539% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 6905.356% |
| MaxCyte, Inc. | -27.76 Million USD | 3310.388% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 17446.903% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 154902.203% |
| Orthofix Medical Inc. | 96.44 Million USD | -824.182% |
| PAVmed Inc | 29.08 Million USD | -2964.361% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 5361.822% |
| RxSight, Inc. | -6.68 Million USD | 13442.814% |
| Sight Sciences, Inc. | -102.71 Million USD | 967.741% |
| SI-BONE, Inc. | 5.72 Million USD | -15479.444% |
| TELA Bio, Inc. | -3.94 Million USD | 22670.271% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -1454.928% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -253110.227% |
| Acutus Medical, Inc. | 12.27 Million USD | -7158.734% |
| Talis Biomedical Corporation | -57.06 Million USD | 1661.93% |
| Spectral AI, Inc. | -3.5 Million USD | 25558.44% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 1955.831% |
| CVRx, Inc. | -59.95 Million USD | 1586.59% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -44821.112% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -69661.599% |
| Bioventus Inc. | 372.51 Million USD | -139.267% |
| Venus Concept Inc. | 74.3 Million USD | -1099.58% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 8853.683% |
| LivaNova PLC | 62.53 Million USD | -1325.35% |
| 908 Devices Inc. | -115.09 Million USD | 874.397% |
| Alphatec Holdings, Inc. | 320.7 Million USD | -177.915% |
| Nemaura Medical Inc. | 9.92 Million USD | -8880.338% |
| NeuroPace, Inc. | 54.33 Million USD | -1540.319% |
| LENSAR, Inc. | -18.31 Million USD | 4967.3% |
| Apyx Medical Corporation | -5.15 Million USD | 17403.436% |
| Cutera, Inc. | 288.3 Million USD | -209.157% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -11760.279% |
| BioSig Technologies, Inc. | 262 Thousand USD | -340090.84% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 2133.539% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 9789.097% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 36.575% |
| Axonics, Inc. | -77.19 Million USD | 1254.623% |
| Outset Medical, Inc. | 67.67 Million USD | -1216.952% |
| IRIDEX Corporation | -4.28 Million USD | 20885.914% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 600.68% |
| IRadimed Corporation | -47.71 Million USD | 1967.803% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 29554.726% |
| INVO Bioscience, Inc. | 8.45 Million USD | -10446.51% |
| Telesis Bio, Inc. | 32.63 Million USD | -2631.117% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 35721.622% |
| Varex Imaging Corporation | 316.9 Million USD | -181.256% |
| Quipt Home Medical Corp. | 81.73 Million USD | -990.482% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 32138.102% |
| Pulmonx Corporation | -42.36 Million USD | 2204.108% |
| Dynatronics Corporation | 6.2 Million USD | -14266.461% |
| Modular Medical, Inc. | -8.04 Million USD | 11183.064% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 20842.378% |
| Semler Scientific, Inc. | -57.13 Million USD | 1660.126% |
| InMode Ltd. | -135.39 Million USD | 758.301% |
| Cytosorbents Corporation | 4.18 Million USD | -21212.693% |
| DexCom, Inc. | 2.02 Billion USD | 56.044% |
| Align Technology, Inc. | -840.47 Million USD | 206.048% |
| Viveve Medical, Inc. | -13.81 Million USD | 6552.617% |
| ZimVie Inc. | 450.41 Million USD | -97.882% |
| Movano Inc. | -5.86 Million USD | 15294.34% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 762.893% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 154902.203% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -44821.112% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | -149.805% |
| Profound Medical Corp. | -18.17 Million USD | 5003.041% |
| Insulet Corporation | 798.1 Million USD | -11.678% |
| enVVeno Medical Corporation | -2.21 Million USD | 40284.851% |
| Surmodics, Inc. | -12.01 Million USD | 7518.845% |
| iCAD, Inc. | -21.2 Million USD | 4302.461% |
| Nuwellis, Inc. | -2.81 Million USD | 31717.595% |
| Biotricity, Inc. | 23.09 Million USD | -3759.656% |
| iRhythm Technologies, Inc. | 93.65 Million USD | -851.725% |
| Aethlon Medical, Inc. | -4.5 Million USD | 19899.354% |
| InspireMD, Inc. | -8.04 Million USD | 11178.931% |
| PAVmed Inc. | 29.08 Million USD | -2964.361% |
| BIOLASE, Inc. | 11.34 Million USD | -7757.017% |
| Beyond Air, Inc. | 6.22 Million USD | -14208.878% |
| FONAR Corporation | -14.66 Million USD | 6177.602% |
| AxoGen, Inc. | 32.26 Million USD | -2662.35% |
| Vivani Medical, Inc. | 42 Thousand USD | -2122042.857% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 8462.732% |
| Inari Medical, Inc. | -7.16 Million USD | 12546.584% |
| UFP Technologies, Inc. | 40.77 Million USD | -2085.952% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -28945.592% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 18780.404% |
| Tenon Medical, Inc. | -1.25 Million USD | 71119.92% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 11818.38% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 7573.392% |
| AdaptHealth Corp. | 2.21 Billion USD | 59.806% |
| Sintx Technologies, Inc. | 905 Thousand USD | -98386.188% |
| NanoVibronix, Inc. | -3.27 Million USD | 27290.36% |
| Quanterix Corporation | -132.95 Million USD | 770.362% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 32138.102% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 4085.245% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | -18.254% |
| TransMedics Group, Inc. | 121.13 Million USD | -635.797% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 3504.507% |
| NeuroMetrix, Inc. | -1.49 Million USD | 59875.866% |
| Hyperfine, Inc. | -75.61 Million USD | 1278.672% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | -485.653% |
| Biomerica, Inc. | -3.38 Million USD | 26430.871% |
| Bone Biologics Corporation | -3.02 Million USD | 29549.188% |
| AVITA Medical, Inc. | -26.23 Million USD | 3497.808% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 48582.086% |
| Silk Road Medical, Inc | 64.42 Million USD | -1283.512% |